PT-141 / Oxytocin
SKU：pt-141-oxytocin
Price：USD 90.00
Product information
This 20 mg blend contains PT-141 and Oxytocin at 10 mg each. Their central-nervous-system research backgrounds involve different pathways: melanocortin receptors for PT-141 and OXTR signalling for Oxytocin. The combination has not been characterized as a single formulation. Individual component mechanisms do not establish the clinical effect or performance of the complete blend.
Product specifications
- Components
- PT-141 + Oxytocin
- Content
- 20 mg per vial (10 mg of each component)
- PT-141
- Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH (bremelanotide)
- Oxytocin
- Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂, CAS 50-56-6
- Form
- Lyophilized powder blend
- Purity
- ≥99% by HPLC
- Appearance
- White to off-white powder
- Solubility
- Water-soluble
- Storage
- -20°C, protected from light
- Classification
- Research use only
Analysis report
No test report for the selected option
Match the product, option and lot in the report.
Research information
Read the full PT-141 / Oxytocin research monograph
Research overview
This 20 mg blend contains PT-141 and Oxytocin at 10 mg each. Their central-nervous-system research backgrounds involve different pathways: melanocortin receptors for PT-141 and OXTR signalling for Oxytocin. The combination has not been characterized as a single formulation. Individual component mechanisms do not establish the clinical effect or performance of the complete blend.